GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Total Liabilities

Bayer AG (XTER:BAYN) Total Liabilities : €83,181 Mil (As of Dec. 2023)


View and export this data going back to 1953. Start your Free Trial

What is Bayer AG Total Liabilities?

Bayer AG's Total Liabilities for the quarter that ended in Dec. 2023 was €83,181 Mil.

Bayer AG's quarterly Total Liabilities declined from Jun. 2023 (€84,543.00 Mil) to Sep. 2023 (€83,695.00 Mil) and declined from Sep. 2023 (€83,695.00 Mil) to Dec. 2023 (€83,181.00 Mil).

Bayer AG's annual Total Liabilities declined from Dec. 2021 (€87,073.00 Mil) to Dec. 2022 (€85,951.00 Mil) and declined from Dec. 2022 (€85,951.00 Mil) to Dec. 2023 (€83,181.00 Mil).


Bayer AG Total Liabilities Historical Data

The historical data trend for Bayer AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Total Liabilities Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78,741.00 86,129.00 87,073.00 85,951.00 83,181.00

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85,951.00 84,035.00 84,543.00 83,695.00 83,181.00

Bayer AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bayer AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29457+(38170+11539
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+4015)
=83,181

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=116259-33078
=83,181

Bayer AG's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=29457+(38170+11539
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+4015)
=83,181

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=116259-33078
=83,181

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bayer AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (XTER:BAYN) Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (XTER:BAYN) Headlines